Avere Therapeutics
PrivateLast Round
Private Placement
Aug 10, 2026
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Avere Therapeutics operates in Healthcare & Life Sciences and is based in Conshohocken, Pennsylvania.
Avere Therapeutics is a biotechnology company developing oral therapies for the treatment of IL-23-driven inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Avere Therapeutics Comparables
Compare Avere Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PepStar Therapeutics | 78% | |
| Protagonist Therapeutics Inc | 77% | |
| Oruka Therapeutics | 76% |
For institutional investors. Book with your work email.
Avere Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Placement | Aug 10, 2026 | ||||
| Private Placement | Jul 14, 2026 |
For institutional investors. Book with your work email.
Avere Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Redmile Group | Private Placement |
| Sirona Capital | Private Placement |
| Janus Henderson Group | Private Placement |
| ADAR1 Capital Management | Private Placement |
| Boyu Capital | Private Placement |
| Balyasny Asset Management L.P. | Private Placement |
| Wedbush Healthcare Partners | Private Placement |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 10, 2026
$500M raised from multiple asset managers and VCs.
- Jul 14, 2026
$320M round led by Fairmount Funds Management and Hansoh Pharmaceutical Group.
For institutional investors. Book with your work email.
Avere Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Avere Therapeutics's valuation, stock price, and market status.
Is Avere Therapeutics a public or private company?
Avere Therapeutics is a private company.
What is the current stock price of Avere Therapeutics?
Avere Therapeutics is a private company, so its shares have no public market price. Caplight tracks Avere Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Avere Therapeutics worth (valuation)?
Valuation information for Avere Therapeutics is not publicly available.
Can I buy Avere Therapeutics stock?
Avere Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Avere Therapeutics's last funding round?
Avere Therapeutics's most recent funding round was Private Placement on August 10, 2026.
Who are the main investors in Avere Therapeutics?
Key investors in Avere Therapeutics include Fairmount Funds Management.
Will Avere Therapeutics IPO soon?
No public IPO plans have been announced for Avere Therapeutics.
How can I track Avere Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Avere Therapeutics's shares on secondary markets.